Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children Aged 5-11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- AXT-Tongmei signs 3-year wafer supply deal with Coherent
FDA Authorizes Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
October 29, 2021 3:12 PM EDTToday, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer (NYSE: PFE) -BioNTech (Nasdaq: BNTX) COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDAs thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.
Key points for parents and caregivers:
Effectiveness: Immune responses of children 5... MoreU.S. FDA authorizes first COVID-19 shot for young kids
October 29, 2021 12:46 PM EDTBy Manas Mishra and Michael Erman
(Reuters) -The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.
The shot will not be immediately available to the age group. The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday.
Pfizer said it will begin shipping... More
Pfizer (PFE)/BioNTech SE (BNTX) COVID-19 vaccine for kids expected to get authorization today - NYT
October 29, 2021 11:59 AM EDTPfizer (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for kids expected to get authorization today - NYT
Active options: PLUG PFE AMC AIRNT HOOD FUTU SNAP BA NIO CLF MRK
October 28, 2021 9:52 AM EDTActive options: PLUG PFE AMC AIRNT HOOD FUTU SNAP BA NIO CLF MRK
... MoreUS Govt Purchases Additional 50M Doses of Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine
October 28, 2021 6:45 AM EDTPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased 50 million more doses of the companies COVID-19 vaccine. The U.S. will receive these additional doses to continue to support preparedness for pediatric vaccinations, including securing vaccines for children under 5 years of age, should they receive regulatory authorization. The companies expect to deliver all these doses by April 30, 2022.
With this order, the U.S. government has... More
Volatility Skew call IV above put IV
October 28, 2021 4:24 AM EDTPfizer (NYSE: PFE) volatility skew call IV above put IV
... More